Announced Thu, 13 Aug · 15:37 IST
Themis Medicare Q1 profit jumps on stake sale; new Company Secretary appointed
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.1%1-day move
₹103.79
prior close
₹103.96
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.4+0.3-0.6+0.0+3.1+2.1+1.1-0.8+2.1+14.8+15.9+15.7——
Up moveDown movePending
AI summary
Themis Medicare Q1 FY27 standalone profit rose to Rs 28.74 cr from a Rs 15.37 cr loss last year. Revenue fell to Rs 86.96 cr from Rs 97.58 cr. Profit included exceptional Rs 99.67 cr from sale of stake in Gujarat Themis Biosyn. Board appointed Suresh Savaliya (ex-Reliance, 23 yrs experience) as new Company Secretary replacing Nagraj Mogaveera who moved to a Deputy Manager role internally.
Likely market impact
Strong Q1 driven mainly by one-time stake sale gain; routine internal change in company secretary role.